dr. tykodi on the clinical implications of the keynote-427 trial in advanced rcc
Published 4 years ago • 27 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
0:59
dr. tykodi on the efficacy of dual checkpoint blockade in rcc
-
2:46
keynote-427 updates: first-line pembrolizumab monotherapy in patients with advanced clear cell r...
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
38:59
new and emerging systemic treatment options for metastatic kidney cancer scott s. tykodi, m.d., phd.
-
7:27
ralph steinman, nobel prize winner, speaks about dendritic cells and immune-based vaccines
-
16:33
facebook live: renal tumors
-
1:08:37
immunology fall 2022: lecture 35 immunotherapy
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
1:28
dr. braun on evolution of immunotherapy in advanced renal cell carcinoma
-
12:22
bridging therapy with tenecteplase or alteplase in patients with large ischemic core
-
4:04
association of gene expression with clinical outcomes in advanced rcc patients treated with pemb...
-
35:47
overview of kidney cancer and recent advances scott tykodi, m.d.kidney cancer association
-
6:06
the combination of sitravatinib and nivolumab for the treatment of advanced clear cell renal cel...
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
5:12
renal cell carcinoma trial analysis: current landscape of immunotherapy combinations
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
7:06
pd-1 inhibition in metastatic renal cell carcinoma
-
2:03
dr. choueiri on savolitinib in papillary renal cell cancer
-
31:45
integration of surgery and systemic therapy for advanced renal cell carcinoma in the targeted the...
-
6:13
dr toni choueiri discusses a phase 2 clinical trial on volitinib in papillary renal cell carcinoma